One of the biggest questions about red light therapy for neuropathy is whether it does anything beyond changing how pain feels.
If a person's feet burn less after treatment, that can matter. But it does not automatically mean the damaged nerves are functioning better.
To investigate that distinction, researchers studying photobiomodulation therapy (PBMT) in diabetic peripheral neuropathy have measured more than pain scores. Studies have looked at nerve conduction, monofilament sensation, vibration perception, plantar pressure, protective sensation, and neuron-related biomarkers.
Some results are encouraging.
But they are not strong enough to support a claim that red light therapy “regenerates nerves” or reverses peripheral neuropathy.
Pain Relief and Nerve Recovery Are Not the Same Thing
Pain is a subjective experience influenced by peripheral nerves, the spinal cord, the brain, inflammation, sleep, mood, and many other factors.
A treatment can reduce pain without rebuilding a damaged nerve.
Conversely, a person with diabetic peripheral neuropathy can have severe sensory loss with little pain at all.
So if we want to ask whether PBMT affects nerve function, objective or semi-objective measures become important.
What Measures Have Researchers Used?
DPN studies have examined outcomes such as:
- Nerve conduction velocity: how quickly electrical signals travel along a peripheral nerve
- Monofilament testing: whether the foot can detect standardized pressure
- Vibration perception: ability to sense vibration
- Protective sensation: whether sensory loss has reached a level that increases risk of unnoticed injury
- Plantar pressure: how pressure is distributed under the foot
- Biomarkers: laboratory markers related to neural injury or function
No single measure proves “nerve regeneration,” but together they can show whether an intervention may be influencing more than pain perception.
What Does the Systematic Review Say?
A 2023 systematic review of eight PBMT studies in diabetic peripheral neuropathy specifically examined neuropathic pain, nerve conduction, and plantar pressure.
The included literature reported improvements in neuropathic pain, nerve conduction velocity, and plantar pressure distribution.
This is one reason the DPN evidence is scientifically interesting: the research signal is not limited to subjective pain scores.
However, the studies varied substantially in protocol and methodological quality, so the review does not establish that PBMT reliably restores nerve function in all patients.
What About Protective Sensation?
A 2025 randomized controlled trial involving 200 people reported improvements in protective sensation and neuropathy-related measures after a defined PBMT protocol applied to the plantar and dorsal surfaces of the feet.
Protective sensation matters clinically because people who cannot feel pressure or injury normally are at higher risk for unnoticed foot damage.
But improvement on a sensory test still should not be translated into “the nerves grew back.”
It means a measured function changed under the conditions of that study.
What About Nerve Conduction?
Nerve conduction studies measure electrical signal propagation along peripheral nerves and are more objective than pain questionnaires.
Some studies summarized in the DPN literature report improvement in nerve conduction measures after PBMT.
That provides a plausible signal that photobiomodulation may affect neural physiology.
Yet not every controlled study agrees.
In a double-blind sham-controlled trial of monochromatic infrared therapy, active treatment did not outperform sham on nerve conduction or several other neuropathy outcomes.
This is exactly why the evidence should be described as promising rather than definitive.
What About Vibration Perception?
Vibration perception is another sensory measure that can become abnormal in peripheral neuropathy.
Foot-focused PBMT research, including work using a laser-shoe delivery design, has reported changes in vibration perception and other neuropathy measures.
Again, the important point is not that a shoe-shaped device is proven to regenerate nerves.
It is that researchers are testing objective sensory outcomes and treatment geometry, not merely asking whether a participant “felt better.”
Why Is Plantar Pressure Studied?
Diabetic neuropathy can change gait, sensation, and how pressure is distributed across the plantar surface.
Abnormal pressure combined with loss of protective sensation can contribute to foot injury risk.
Some PBMT studies have reported changes in plantar pressure distribution.
This is an interesting functional outcome, but it is indirect. A change in plantar pressure is not equivalent to regeneration of the peripheral nerves.
What About Biomarkers?
The 2025 200-participant trial also investigated neuron-related biomarkers and reported changes alongside clinical outcomes.
Biomarkers can help researchers explore possible mechanisms, but they should not be treated as a stand-alone clinical endpoint.
A laboratory marker changing does not automatically mean a person's neuropathy has been reversed.
Why the Negative Studies Matter
If every positive paper is highlighted while negative research is ignored, the result is marketing rather than evidence review.
The older sham-controlled infrared trial found no advantage for active treatment across several sensory, electrophysiological, and quality-of-life measures.
Different studies used different wavelengths, devices, doses, schedules, and populations.
That tells us something important:
“Light therapy” is not one standardized intervention.
Clinical outcomes depend on the actual treatment parameters, and one positive device cannot validate every other red or infrared product.
Can We Say Red Light Regenerates Nerves?
Not from the current clinical evidence.
There are laboratory and preclinical reasons to investigate PBMT for neural repair. There are also human DPN studies showing changes in objective measures.
But “nerve regeneration” is a much stronger claim than:
- Pain decreased
- Monofilament sensation improved
- Nerve conduction changed
- Vibration perception improved
- A biomarker shifted
Until larger, well-controlled studies demonstrate durable structural or functional recovery, saying that PBMT regenerates diabetic nerves goes beyond the evidence.
Can Red Light Reverse Neuropathy?
For the same reason, “reverse neuropathy” is too strong.
The ADA Standards of Care in Diabetes—2026 continue to emphasize prevention, metabolic risk management, symptom treatment, and foot protection rather than a therapy that restores lost peripheral nerve function.
PBMT can be investigated as an adjunct without pretending that this larger clinical problem has been solved.
Does the Evidence Apply to Every Type of Neuropathy?
No.
Most of the foot-specific human evidence discussed here comes from diabetic peripheral neuropathy.
That should not automatically be applied to:
- Chemotherapy-induced neuropathy
- Vitamin B12 deficiency
- Nerve compression
- Alcohol-related neuropathy
- Small-fiber neuropathy from other causes
- Idiopathic neuropathy
If your main question is about symptoms rather than a confirmed diagnosis, see Red Light Therapy for Foot Neuropathy: Can It Help Numbness and Tingling?.
What Should Consumers Take From the Research?
Three things.
1. There is more than pain research. Objective and sensory outcomes have been investigated.
2. Positive findings are not uniform. Some controlled studies are negative.
3. Device equivalence cannot be assumed. A home LED product does not become clinically proven because a laser study reported an improvement.
For the broader DPN evidence, including study-by-study context, see Does Red Light Therapy Help Diabetic Peripheral Neuropathy? What the Evidence Says.
What Role Does Dose Play?
Photobiomodulation depends on the dose actually delivered to tissue.
Relevant variables include wavelength, irradiance, exposure time, area, distance, and treatment schedule.
That is why studies using different devices should not be treated as though they tested the same intervention.
For an explanation of PBM dose and wavelengths, see Sissilux: The Science.
Frequently Asked Questions
Does red light therapy heal damaged nerves?
Human DPN studies show some encouraging changes in nerve-related and sensory measures, but they do not establish that PBMT heals or regenerates damaged peripheral nerves.
Can sensation come back after red light therapy?
Some studies report improvements in sensory testing, including protective sensation or monofilament measures. Results are not uniform and should not be generalized to every neuropathy.
Is less pain proof that the nerve is recovering?
No. Pain relief and nerve recovery are different outcomes.
Is nerve conduction a stronger outcome than pain?
It is more objective, but even a change in nerve conduction does not by itself prove structural nerve regeneration.
The Bottom Line
The most interesting PBMT research in foot neuropathy goes beyond pain.
Studies have reported changes in nerve conduction, protective sensation, vibration perception, plantar pressure, and biomarkers. That suggests photobiomodulation may influence neural or sensory function under some treatment conditions.
But the total evidence remains heterogeneous, and negative sham-controlled research exists.
So the scientifically defensible conclusion is:
Red light therapy may influence some symptoms and measurable nerve-related outcomes in diabetic peripheral neuropathy, but current evidence does not prove nerve regeneration or reversal of neuropathy.
